For the Inventor, By the Inventor

Enter assignee name

Laberge, France

Genticel

USPTO Granted Patents = 8

CIPO Patents = 4

EPO Patents = 4

Forward Citations = 10

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Yolande Misseri (4 out of 4 patents)

Benedikt Timmerman (4 out of 5 patents)

Daniel Ladant (3 out of 14 patents)

4. Claude Leclerc (3 out of 25 patents)

5. Xavier-Edmond-Edouard Preville (3 out of 3 patents)

6. Michael Esquerre (2 out of 2 patents)

7. Etienne Joly (2 out of 2 patents)

8. Anne Goubier (2 out of 2 patents)

9. Michael Esquerré (1 out of 1 patent)

10. Marie Momot (1 out of 1 patent)

11. Philippe Bridonneau (1 out of 1 patent)

12. Xavier Preville (1 out of 1 patent)

13. Xavier-Edmond-Edouard Preville (0 patent)

8 patents: Sort by Forward Citations

1. 9982024 - CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses (2018-05-29),

2. 9902947 - CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses (2018-02-27),

3. 9827302 - HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders (2017-11-28),

4. 9499809 - CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses (2016-11-22),

5. 9486524 - Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells (2016-11-08),

6. 9387243 - Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof (2016-07-12),

7. 8637039 - Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof (2014-01-28),

8. 8628779 - Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof (2014-01-14),

Genticel is a biotechnology company focused on developing immunotherapies to prevent and treat HPV-related diseases, such as cervical cancer. The company's lead product candidate, ProCervix, is a therapeutic vaccine designed to induce a specific immune response against HPV. Genticel is committed to improving women's health through innovative treatments and technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#1 in Laberge

#1,188 in France

Laberge, France

Genticel

Forward Citations = 10

14 inventors:

Yolande Misseri (4 out of 4 patents)

Benedikt Timmerman (4 out of 5 patents)

Daniel Ladant (3 out of 14 patents)

4. Claude Leclerc (3 out of 25 patents)

5. Xavier-Edmond-Edouard Preville (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…